Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Eisai to collaborate with Toyama in development, marketing of DMARD

Nov. 5, 1998

Inhibitors of cell adhesion with antiinflammatory activity developed at Japan Energy

Nov. 5, 1998

SmithKline Beecham describes new cannabinoid receptor agonists

Nov. 5, 1998

Aryl C-glycosides as selectin inhibitors jointly developed by Sankyo, Glycomed

Nov. 5, 1998

Potent and selective COX-2 inhibitors from Merck Frosst useful for inflammation

Nov. 4, 1998

Korean laboratory prepares new series of TNF-alpha inhibitors

Nov. 4, 1998

FDA approves, Immunex launches breakthrough treatment for RA

Nov. 3, 1998

Orally active collagenase inhibitor Ro-32-3555 shows potential for osteoarthritis Rx

Nov. 3, 1998

Preparation and use of TNF-alpha and MMP inhibitors described by Novartis

Nov. 3, 1998

Safety and efficacy of COX-2 inhibitor established in phase II trials

Nov. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.